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Basic 001 
EFFECTS OF ANTIOXlDANTS ON INTERLEUKIN-lp, NITRIC 
OXIDE AND PROSTAGLANDIN E2 PRODUCTION BY HUMAN 
CHONDROCYTES 
M. Mathy-Hartert*, N. Ayachet, K. Boumedienet, J.-P. Pujoll, 
J.-Y. Reginster °, Y. Henrotin'. 
*Bone and Cartilage Metabolism Research Unit, University of 
Liege, Belgium; tLaboratory of Connective Tissue Biochemistry, 
University of Caen, France 
Reactive oxygen species (ROS) were reported to trigger cartilage 
and connective tissue degradation suggesting their roles in the 
pathophysiology of joint diseases. These ROS were essentially the 
superoxide anion (O z ) and the nitric oxide (NO) produced by 
NADPH oxidase and NO synthase respectively. 02- and NO 
rapidly react to form peroxynitrite anion (ONOO-), a strong oxi- 
dant. The oxidative power of the ROS induces tissue damage but 
also the activation of some nuclear transcription factors such as 
NF-KB and AP-I. These factors regulate the expression of a 
number of genes involved in inflammation and especially in the 
pathogenesis of rheumatoid arthritis and osteoarthritis. The objec- 
tive of the present study was to investigate the effects of two 
antioxidants, N-monomethyI-L-arginine (L-NMMA) and 
N-acetylcysteine (NAC), on IL-113, NO and prostaglandin E 2 
(PGE2) productions by human chondrocytes. The effect of ace- 
clofenac (ACE), a non steroidal anti-inflammatory drug (NSAID), 
was also examined. 
Human chondrocytes were enzymatically isolated from normal 
young cartilage and then seeded at high density in culture flasks. 
After a wash-out period of 48 H, chondrocytes were cultured for 48 
H in the absence or in the presence of lipopolysaccharide (LPS) 
(10 tJg/ml), L-NMMA (0.5 mM), NAC (1 mM) or ACE (2 p/ml). 
Culture medium was DMEM W/O red phenol supplemented by 
2 mM glutamine and 1% of TS+. TS+ is a premixed culture 
medium containing transferrin, selenium, linoleic acid and BSA. 
Cell extracts were used to examine the expression of IL-113, iNOS 
and COX-2 genes (RT-PCR technique) while IL-I~, PGE 2 (immu- 
noassay) and NO (Griess reaction) were measured in conditioned 
culture supernatants. 
The expression of IL-113, iNOS and COX-2 genes was markedly 
increased by the treatment with LPS. In parallel, NO and PGE2 
amounts found in the culture supernatants were also enhanced 
whereas IL-113 was undetectable. The addition of L-NMMA fully 
blocked LPS-induced NO production but highly increased PGE 2 
production suggesting a negative effect of NO on PGE 2 synthesis. 
Inversely, NO production was stimulated by NAC while PGE 2 
production was not affected. As expected, ACE inhibited PGE 2 
production but had no significant effect on NO production. Interest- 
ingly, the expression of iNOS, COX-2 and IL-I~ genes was 
unaffected by the antioxidants or ACE suggesting a post- 
transcriptional effect of these drugs. 
In conclusion, the stimulation of IL-I~, NO and PGE 2 productions 
by LPS is differentially controlled by ROS at the mRNA levels. In 
fact, L-NMMA and NAC show opposite effects on NO and PGE 2 
productions whereas gene expressions are not affected. A possible 
mechanism of the action of NO or ONOO- on COX-2 enzymatic 
activity could be achieved by nitroso or nitrotyrosine formation on 
the catalytic site of the enzyme. 
This work was supported by an unrestricted educational grant from 
UCB Pharma. 
Basic 002 
p53 RELATES TO APOPTOSIS OF CHONDROCYTES AND 
BONE CELLS IN IMMOBILIZED KNEE 
R. Okazaki, A. Sakai', A. Ootsuyama, T. Sakata, T. Nakamura', 
T. Norimura 
Department of Radiation Biology and Health, *Department of 
Orthopaedic Surgery, Sch. of Med., Univ. of Occupational & 
Environmental Health, Kitakyushu, Japan 
Objectives: We previously reported that articular cartilage 
showed the early stage degeneration at 7 and 14 days after 
immobilization, the moderate at 28 days, and the severe at 42 days 
(Ann Rheum Dis 1996; 55:181-6). In the present study, we 
compared the frequency of apoptotic cells in p53 null (p53(-/-)) 
and wild-type p53(+/+) mice and rabbits after immobilization. 
Materials and Methods: Right knees of male Japanese white 
rabbits (6-month-old, 3 kg) were immobilized in full extension with 
fiberglass casts for 0, 7, 14, 21, 24, 28 and 42 days. Apoptotic ells 
were confirmed by TUNEL staining on the sections of knee joints at 
24 days after immobilization. Total RNAs of chondrocytes obtained 
from non-immobilized or immobilized rabbit knees were analyzed 
quantitatively with using RT-PCR method. Amplification of gener- 
ated cDNA was performed with specific primer of p53. Right knees 
of male p53(-/-) mice and p53(+/+) mice (8-week-old) were also 
immobilized in full extension with bandage for 14 days. The knee 
joints were stained by TUNEL method. 
Results: Apoptotic cells were observed in articular cartilage, 
trabecular bone and growth plate in rabbit femur and tibia 28 days 
after immobilization. Especially, the number of apoptotic cells in 
superficial layer of cartilage were higher than in deep layer. The 
percentages of apoptotic ells in articular cartilage were 11.3% at 
24 days after immobilization. Furthermore, some osteocytes or 
osteoblasts also were stained as apoptotic cells. In RT-PCR 
analysis, the expression of p53 mRNA obtained from immobilized 
groups (21,24, 28 and 42 days) were significantly higher than that 
of non-immobilized group. Apoptotic cells were observed in articu- 
lar cartilage, meniscus, trabecular bone and growth plate in knee 
joints in p53(+/+) mice, but not in any parts in p53(-/-) mice. 
Apoptotic cells in articular cartilage were observed 12.4% in 
p53(+/+) mice. 
Conclusion: We conclude that p53 relates to apoptotic cell 
death in chondrocytes and bone cells in degenerated cartilage 
induced by immobilization. 
Basic 003 
TRANSCRIPTION FACTOR ERG VARIANTS AND 
FUNCTIONAL DIVERSIFICATION OF CHONDROCYTES 
DURING LIMB SKELETOGENESlS 
M. Iwamoto*, Y. Higuchi*, M. Enomoto-lwamoto*, K. Kurisu*, 
E. Koyama, H. Yeh, W. R. Abrams, M Pacifici, and J. Rosenbloom 
*Osaka University Faculty of Dentistry Osaka, Japan; and 
University of Pennsylvania School of Dental Medicine, 
Philadelphia, USA 
During limb development, chondrocytes undertake two develop- 
mental pathways. Those at the epiphyseal tip of long bone anlagen 
give rise to articular cartilage which persists throughout life, 
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whereas the more numerous chondrocytes in the shaft undergo 
maturation and hypertrophy and are eventually replaced by bone 
cells. It is not understood how chondrocytes follow these alterna- 
tive pathways to distinct fates and functions. Here we describe the 
cloning of C-1-1, a novel variant of the ets transcription factor 
ch-ERG that lacks a 27 amino acid segment located approximately 
80 amino acids upstream of the ets DNA binding domain. We 
found by in situ hybridization and quantitative RT-PCR that C-1-1 is 
preferentially expressed in developing articular chondrocytes, 
whereas ch-ERG characterizes both articular and ,growth plate 
chondrocytes in the cartilaginous anlagen of chick embryo limbs. 
To analyze the function of C-1-1 and ch-ERG, viral vectors were 
used to constitutively express each factor in developing chick leg 
buds and cultured chondrocytes. We found that virally-driven 
expression of C-1-1 maintained chondrocytes in a stable pheno- 
type, blocked their maturation into hypertrophic cells, and pre- 
vented the replacement of cartilage with bone. It also induced 
synthesis of tenascin-C, an extracellular matrix protein which is a 
unique product of developing articular chondrocytes, and expres- 
sion of a tenascin-C promoter construct. In contrast, virally-driven 
expression of ch-ERG significantly stimulated chondrocyte matu- 
ration, as indicated by increases in alkaline phosphatase activity 
and mineral deposition. The data show that C-1-1 and ch-ERG 
have diverse biological properties and distinct expression patterns 
during skeletogenesis and are part of molecular mechanisms by 
which chondrocytes follow alternative developmental pathways. 
We believe that C-1-1 is the first transcription factor identified to 
date which appears to be instrumental in the genesis and function 
of epiphyseal articular chondrocytes. 
Supported by NIH grants and Ministry of Education, Science and 
Culture of Japan. 
radiolabeled oligonucleotides. The nuclear extracts were obtained 
from human chondrocytes after 1 hour or 12 hours of pretreatment 
with the ligand followed by 1 hour of IL-1 [5 stimulation. 
Results: For the first time, we demonstrated the presence of 
PPARc~, PPARy and RZRc~ in human chondrocytes, at both mRNA 
and protein levels. If PPARc~ mRNA expression remained unmodi- 
fied after IL-I~ treatment, PPAR 7 mRNA was significantly 
decreased, whereas RZRo~ mRNA was strongly and dose- 
dependently increased (+250% at 250 U/ml of IL-115). We also 
found that OA chondrocytes were more sensitive to IL-l~ than 
normal chondrocytes, regarding the modifications of PPARy and 
RZRc~ expression. These results would suggest that the three 
factors should be unequally involved in the effects of IL-1l~ 
chondrocytes. A pre-incubation with PPAR~- or RZRct-ligands did 
not allow to modulate IL-1 [5-induced iNOS and COX-2 expression 
or PG synthesis decrease. If troglitazone was also ineffective on 
these parameters, interesting results were obtained with 15d-PGJ2 
at 10 pM. It completely abolished IL-l[5-induced iNOS expression 
and NO production and led to a 65% reduction of COX-2 expres- 
sion. Moreover, 15d-PGJ2 partly restored the PG anabolism 
(45%). Finally, gel shift assay showed that 15d-PGJ2 decreased 
both IL-l~-induced NF-KB and AP-1 activity with earlier effects on 
NF-~B pathway. 
Conclusions: These results show that the agonists of PPARo~ 
and RZRcc were inefficient o counteract the IL-lJ5 effects on human 
chondrocytes. They also strongly suggest that 15d-PGJ2 is able to 
modulate the deleterious effects of IL-I~ on human cartilage by 
antagonizing NF-~:B and/or AP-1 pathways. However, since trogli- 
tazone (which is a PPARy specific ligand) did not exhibit any 
significant action, the partial or total involvement of PPAR 7 in the 
effects of 15d-PGJ2 remains to be elucidated. 
Basic 004 
CHARACTERIZATION OF PEROXISOME 
PROLIFERATOR-ACTIVATED RECEPTOR-a AND -7 AND 
RETINOID Z RECEPTOR IN HUMAN CARTILAGE. EFFECT 
OF SPECIFIC AGONISTS ON IL-1-STIMULATED 
OSTEOARTHRITIC CHONDROCYTES 
S. Boyault', K. Bor_dj!*, M.-A. Simonin*, A. Bianchil-, M. Dau~al, 
P. Netter* and B. Terlain* 
°Laboratoire de Pharrnacologie, UMR CNRS 7561, Vandoeuvre- 
les-Nancy, France; "tLaboratoire de Biologie du Developpement, 
UPRES 2402, Vandoeuvre-les-Nancy, France 
Aim of the study: PPARoq PPARy and RZRo~ belong to the 
superfamily of nuclear receptors which are ligand-activated tran- 
scription factors. Although they are mainly involved in the lipid and 
glucose metabolism and in cell differentiation, these receptors 
have been shown to modulate cell activation by inhibiting both the 
production and the effects of cytokines. However, to date, PPARcq 
PPARy and RZRo~ have never been studied in human cartilage. 
Since IL-113 is known to directly mediate cartilage degradation in 
osteoarthritis (OA), the aim of this work was to investigate the 
capability of specific ligands to modulate IL-115 effects on human 
OA chondrocytes. 
Methods: RT-PCR and Western blot analysis were performed to 
evidence the presence of mRNA and protein of PPARcq PPAR 7 
and RZR(z in cultured human OA and normal chondrocytes. Cells 
were then stimulated with IL-I~ (50 U/ml) for 15hours in the 
presence or absence of ligands [10 pM troglitazone and 10 pM 
15d-A 12'14 prostaglandin J2 (15d-PGJ2) for PPART, 250pM 
Wy-14,643 for PPARoq 10 pM CGP-52608 for RZRcq and iNOS 
and COX-2 mRNA expression was quantitated. Proteoglycan 
anabolism was assessed by incorporation of radiolabelled sodium 
sulphate and NO production was measured according to the 
method of Griess. The effects of PPARy ligands (troglitazone and 
15d-PGJ2) on IL-11]-induced NF-~B and AP-1 DNA binding activity 
were further assayed in gel-shift experiments using specific 
Basic 005 
REGULATION OF TYPE II COLLAGEN GENE EXPRESSION 
DURING HUMAN CHONDROCYTE DE-DIFFERENTIATION 
AND RE-DIFFERENTIATION 
D. G. Stokes, G. Liu, R. Dharmavaram and S. A. Jimenez 
Division of Rheumatology, Department of Medicine, Jefferson 
Medical College, Thomas Jefferson University, Philadelphia, USA 
Chondrocytes are highly specialized cells that are responsible for 
the production and assembly of the abundant extracellular matrix 
of all cartilaginous tissues including articular cartilage. During ex 
vivo growth of chondrocytes as monolayer cultures they change 
morphology from a spherical cell shape to a more flattened 
spread-out cell shape and also change from expression of 
chondrocyte-specific genes, such as types II, IX, and XI collagen 
and aggrecan, to genes that are normally fibroblast products 
including types I and III collagen and versican. Upon transfer of the 
monolayer chondrocyte culture to a three-dimensional culture 
system, such as on poly-(2-hydroxyethyl) methacrylate hydrogels 
(polyHEMA), agarose, alginate, or certain artificial scaffolds, the 
cells slow their proliferative rate and reacquire the chondrocyte- 
specific phenotype (re-differentiate) and can produce a 
cartilaginous-like tissue in vitro. We investigated the mechanisms 
controlling the reversibility of the chondrocyte phenotype by cultur- 
ing human fetal epiphyseal chondrocytes on tissue culture plastic 
for multiple passages followed by re-plating on polyHEMA coated 
dishes. As assayed by morphology, RT-PCR of chondrocyte- 
specific gene expression and measurement of type II collagen 
promoter activity, we show that in this system the chondrocytes 
-can reacquire their chondrocyte-specific phenotype after two serial 
four-week passages in monolayer. We also show that the activity 
of a reporter construct containing the promoter and enhancer from 
the human COL2A1 gene was modulated by the culture conditions 
in that its transcriptional activity was repressed in monolayer and 
rescued when the cells were switched to polyHEMA and 
re-differentiated. Further investigation by electrophoretic mobility 
shift analyses indicated that the binding of the Sox transcription 
factors, Sox9, 6, and L-Sox-5, to the enhancer region is modulated 
by the phenotype reversal process. We theorize that modulation of 
expression or availability of Sox transcription factors may be 
responsible for the observed down- and up-regulation of 
chondrocyte-specific genes that occurs during de-differentiation 
and re-differentiation, respectively. 
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EFFECT OF CERAMIDE ON AGGRECANASE ACTIVITY IN 
RABBIT ARTICULAR CARTILAGE 
M. Sabat!ni, C. Deschamps, M. Thomas, C. Lesur, G. Rolland, 
G. de Nanteuil', and J. Bonnet 
Rheumatology Division and *Medicinal Chemistry Division, Institut 
de Recherches Servier, Suresnes, France 
Aims of the study: Ceramide is thought to participate in signal 
transduction of IL-1 and TNF, two inflammatory cytokines likely to 
be involved in cartilage degradation in osteoarthritis. It has been 
previously shown that ceramide increases proteoglycan degrada- 
tion, mRNA expression of MMP-1, -3 and -13 as well as pro- 
MMP-3 availability in cartilage. The aim of the present study was to 
examine the effect of ceramide on the activity of aggrecanases, 
metalloproteinases of the ADAMTS family that cleave aggrecan at 
different sites compared to MMPs. 
Methods: Explant cultures of rabbit articular cartilage were used 
in all experiments. For studies of aggrecanase activity, cartilage 
was cultured with or without reatments for 4 days, then proteogly- 
cans were extracted, deglycosylated and analysed by Western blot 
using antibodies that recognize aggrecan neoepitopes produced 
by either agrecanases (-NITEGE) or MMPs (-VDIPEN). For studies 
of proteoglycan degradation, cartilage fragments were first labeled 
with 35SO4, then cultured with or without treatments for 3 days. 
Degradation was measured by the percentage of radioactivity 
released into the culture media. 
Results: Ceramide C2 at 10 .5 to 10 .4 M dose-dependently 
increased NITEGE signal without changing that of VDIPEN. The 
effect of 10 .4 M ceramide on NITEGE was antagonized by the 
MMP and aggrecanase inhibitor batimastat, starting at 10 .8 M with 
return to the basal level at 10 .6 M. A similar pattern of dose- 
dependent inhibition by batimastat was observed on ceramide- 
induced proteoglycan degradation. 
Conclusions: These results show that, similarly to what is 
described for IL-1, ceramide-induced aggrecan degradation is 
mainly due to aggrecanases. That no increase of MMP activity was 
detected despite stimulation of MMP production is probably due to 
the lack of pro-enzyme activation. These findings support the 
hypothesis that ceramide generated by cytokine-activated sphin- 
gomyelinases could play a mediatory role in situations of increased 
degradation of cartilage matrix. 
Acknowledgements: antibodies were kindly provided by Prof. M. T. 
Bayliss (Royal Veterinary College, London, UK) 
Basic  007 
MESENCHYMAL STEM CELL THERAPY FOR 
OSTEOARTHRITIS: RETENTION AND DISTRIBUTION OF 
AUTOLOGOUS MESENCHYMAL STEM CELLS IN THE GOAT 
OSTEOARTHRITIC KNEE 
J. M. Murphy, K. W. Kavalkovich, F. P. Barry 
Osiris Therapeutics Inc., Baltimore, USA 
The application of stem cells to the arthritic joint has potential in 
slowing disease progression by stimulating regeneration of eroded 
cartilage. In this study we evaluated the direct delivery of mesen- 
chymal stem cells (MSCs) to the intact osteoarthritic joint in the 
absence of a solid biomatrix. The merit of this approach lies in the 
simple delivery system used and the avoidance of an open surgical 
procedure. In this initial evaluation labeled cells were injected into 
the knee joints of goats in which osteoarthritis was induced by 
creation of instability. Hyaluronan was included as a component in 
the delivery system as it has been shown to promote chondro- 
genesis of MSCs. 
Twelve goats received either resection of the anterior cruciate 
ligament (ACL), (n=6) or total medial meniscectomy (n=6). After a 
2-week recovery period, the goats were exercised 5 days each 
week for 12 weeks. At 12 weeks autologous, green fluorescent 
protein (GFP)-transduced MSCs were introduced into both oper- 
ated and contralateral joints. All goats received injections of 5 ml of 
a 1 x 10 s cell/ml suspension with hyaluronan (4 mg/ml, n=3) or with 
PBS (n=3). All animals were sacrified seven days after injection. 
Synovial fluid and synovial fluid lavage, and samples of capsule, 
fat pad, tendon, ligament, meniscus and normal and fibrillated 
cartilage were collected, fixed and embedded in paraffin. Synovial 
fluid and lavage smears, and sections from all tissues were 
analyzed for the presence of fluorescent cells using confocal and 
standard microscopy. Cells were also isolated from the synovial 
fluid and cultured using standard conditions. 
As expected, goats subjected to ACL resection developed symp- 
toms of mild osteoarthritis whereas medial meniscectomy resulted 
in more severe changes. GFP-transduced cells were detected in 
the synovial fluid and synovial fluid lavage from all joints. Implanted 
cells collected from the synovial fluid were expanded in culture 
demonstrating viability. Fluorescent microscopy revealed that the 
transduced MSCs had colonized and integrated with surface layers 
of soft tissue within the joint. Specifically, GFP was detected in the 
synovial/capsule lining, and at the surface of menisci and fat pad. 
No detectable differences were observed when hyaluronan was 
included. Analysis of the cartilage surface from the medial and 
lateral middle condyles and from the medial and lateral 
unprotected tibial plateaus of all goats by fluorescence microscopy 
showed that GFP-transduced cells did not bind to cartilage. 
GFP-positive cells were found in some areas of synovial lining on 
both the intracondylar aspect that the outer aspect of the lateral 
and medial condyles. 
These observations demonstrate that MSCs can be successfully 
delivered to an oste'oarthritic joint by direct injection, that they are 
retained within the joint, colonize soft tissue surfaces, and can be 
recovered in a viable form after one week. Based on these 
observations the arthroscopic or direct delivery of MSCs to the 
osteoarthritic joint represents a potentially beneficial cell therapy 
approach. 
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IN VITRO CHARACTERIZATION OF ARTICULAR CARTILAGE 
STRUCTURE: A COMPARATIVE QUANTITATIVE MRI AND 
MICROSCOPIC STUDY 
M. T. Nieminen*, J. Rieppo °, J. T6yr&sl, J. M. Hakum&ki:l:, 
M J. Silvennoinen:l:, M. Hyttinen', J. S. Jurvelinl- and 
H. J. Helminen" 
*Department of Anatomy, University of Kuopio; ?D~partment of 
Clinical Physiology, Kuopio University Hospital; SA. I. Virtanen 
Institute for Molecular Sciences, University of Kuopio, Finland 
MRI provides the only potential non-invasive techniques for the 
characterization of articular cartilage constituents. In this study, a 
quantitative approach was conducted to verify two potential MR 
techniques for the analysis of cartilage: (i) T 2 mapping of collagen 
network and (ii) GdDTPA2-enhanced T 1 mapping of cartilage 
proteoglycans (PGs). 
To investigate the sensitivity of T 2 relaxation on the collagen fibril 
organization, osteochondral plugs from healthy articular cartilage 
(dia.=6 mm, n=9) were prepared from patellae of 1 to 3-year-old 
bulls, one sample per patella. With cartilage surface normal to the 
static magnetic field, MR imaging at 9.4T was performed on the 
samples using a Hahn spin echo sequence (TR/TE=2500/ 
14,24,34,44 ms). m 2 maps with 78*78 pm in-plane resolution were 
obtained, and a depthwise T 2 profile for each sample was calcu- 
lated. Quantitative polarized light microscopic measurements were 
performed on microscopic sections from the same samples to 
reveal the organization of fibrillar collagen (optical retardation, OR). 
Correlation of spatial T 2 relaxation and OR data was performed. 
To evaluate the spatial sensitivity of GdDTPA 2- contrast agent 
enhanced T1 imaging of articular cartilage PGs, cartilage disks 
without subchondral bone (dia.=4 mm, n=5) were harvested from 
bovine patellae. Saturation recovery experiments were performed 
for each sample after PBS immersion and after 2.5 h immersion in 
1 mM GdDTPA, with TE=14ms and 6 time points between 
TR=200-5000ms for PBS immersed samples and TR=100- 
1500ms for GdDTPa 2- immersed samples. T 1 maps with 
39*39 pm in-plane resolution were obtained and [GdDTPA 2-] 
profiles were calculated. [GdDTPA 2-] is assumed to distribute in 
inverse relation to negative PGs. Spatial PG concentration of 
safranin O stained tissue sections were measured microscopically 
as optical density (OD). 
T 2 maps and OR images appeared highly similar. A high correlation 
between spatial T 2 and I/OR data was established in each sample 
(r=50.93±0.02, n=9). Pooling data from all samples (n=194) 
resulted in r=0.69. These results reveal the close connection 
between laminar T 2 appearance and zonal interpretation of carti- 
lage, based on changes in collagen arrangement. Pooling data, 
however, suggests the existence of additional contributors to both 
techniques, and debilitates straightforward quantitative prediction 
of one parameter by the other. Nonetheless, the spatial agreement 
of these two different echniques reveals that T 2 changes in normal 
articular cartilage reflect sensitively architectural changes in 
collagen fibril arrangement. 
Equalization of MR and OD data allowed the quantitative spatial 
comparison of GdDTPA 2- enhanced T1 profiles and [GdDTPA 2-] 
profiles with OD profiles of each sample. A significant inverse 
relation was observed between [GdDTPA 2-] and PG concen- 
tration, mean r=-0.91+0.02 (n=5) and r=-0.89 after pooling all 
data points (n=179). T~ alone in the presence of GdDTPA 2- 
correlated well with PG concentration, r=0.87±0.04 (n=5). Inter- 
estingly, [GdDTPA 2-] or T 1 in the presence of GdDTPA 2- corre- 
lated less successfully with OD in deep tissue of some samples, 
indicating incomplete penetration of the contrast agent. As diffu- 
sion time was sufficient, this is probably due to the high negative 
charge or high solid content in deep cartilage of some samples. 
The current results demonstrate the ability of the assessed MR 
techniques to quantitatively probe the structure of articular carti- 
lage. Furthermore, the findings raise hopes for quantitative diag- 
nostic techniques, although further in-depth research is necessary. 
C l in ica l  001 
POPULATION REQUIREMENT FOR PRIMARY TOTAL KNEE 
REPLACEMENT: A COMPARISON WITH HIP REPLACEMENT 
P. J~3ni, S. Frankel, J. Donovan, P. Dieppe 
MRC Health Services Research Collaboration, Department of 
Social Medicine, University of Bristol, United Kingdom 
Aim: Total joint replacements are the treatment of choice in 
patients with severe osteoarthritis of the knee, but there is uncer- 
taint,/about he appropriate level of untilisation of this intervention. 
Therefore, we set out to determine the population requirement for 
primary total knee replacement (TKR) in England, and to compare 
it with the requirement for primary total hip replacement (THR). 
Methods: We performed a cross-sectional study of an age/sex 
stratified random sample of 28080 individuals aged 35 and over 
from 40 general practices in inner-city, urban, and rural areas of 
Avon and Somerset, England. Prevalent disease was determined 
through a two-stage process: a self-report screening questionnaire 
and subsequent clinical examination. Incident knee disease was 
estimated from the point prevalence by statistical modelling. The 
requirement for T JR was determined on the basis of pain and 
disability, using the New Zealand priority criteria for major joint 
replacement (Hadorn D. et al, BMJ 1997) with a previously 
published cut-off point to reflect disease severity requiring inter- 
vention. Finally we modified the number requiring surgery to 
exclude those who were unfit for surgery, those who were against 
a surgical intervention, and those who had not had an adequate 
trial of medical therapy, and compared results to those previously 
published for THR using the same methods (Frankel Set  al, 
Lancet 1999). 
Results: After exclusion of 2034 people for reasons of moving 
out of the study area, terminal illness, death or severe mental 
illness, 26046 people were included in the study. 22978 responded 
to the screening questionnaire (88.2%), with 4799 reporting knee 
pain. 3311 were invited for clinical examination, and 2117 attended 
(63.9%). The prevalence of self-reported knee pain was 236 per 
1000 (95% CI 228-244) for women, and 188 per 1000 (181-197) 
for men. The prevalence of knee disease severe enough to require 
T JR was 18.3 per 1000 (16.0-20.8). The corresponding annual 
incidence of knee disease requiring TKR was 2.31 per 1000 
(1.74-2.89) for those aged 35 and over, which translates into an 
overall requirement of 47000 operations per year for patients who 
were fit for surgery. This contrasts with the provision actually 
observed 1996 in England of about 28500 TKR. The table shows 
the effect of modifying the estimated number of TKR in comparison 
with respective estimates for THR. Unlike for hips, the number of 
TKR decreased considerably to less than half of the initially 
estimated number after exclusion of those who were against a 
surgical intervention, and those who had not had an adequate trial 
of medical therapy. 
Estimaled annual incident eases 
expressed as lO00s of joints (CL) 
TKR THR 
Es{Lrnated population incidence 56.9 (41 9-71 3) 54.0 (35,9-72 I) 
Fit for surgery 470 (32 1-61 8) 52.4 (329-71.8) 
Posilive preference and fil 32.6 (19.3-45 8) 479 (29.(~66.8) 
Fit arid on medicalion 33.4 (20 6-46.2) 49.2 (30.2-68.3) 
Positive pfelefence, fit and on medication 25.7 (13.9-37.5) 46.2 (27.5-64.9) 
Conclusions: The data indicate underprovision of TKR in Eng- 
land. However, this may not be due to the failure of the service to 
satisfy needs. Our findings suggest that negative perceptions 
about treatments for knee OA, including TKR, may be a major 
barrier to the appropriate utilisation of resources. 
Clinical 002 
THE INHERITANCE OF HIP OSTEOARTHRITIS IN ICELAND 
13. Ingvarsson*¶, S. E. Stefanssonl, H. Jonsson Jr-J:, J. Gulcher:l:, 
H. Jonsson:l:, I. Hallgrimsdottirt, J. R. Ragnarssonl, 
L. S. Lohmande~, and K. Stefanssonl 
*Central Hospital Akureyri, ~r deCode Genetics Reykjavik, 
~.University Hospital Reykjavik, §City Hospital Reykjavik, Iceland, 
and ¶Lund University Hospital, Sweden 
Objective: To assess, in a population-wide study in Iceland, the 
genetic contribution to hip osteoarthritis (OA) leading to total joint 
replacement. 
Materials and Methods Information from two computerized, 
population-based, databases were combined: a national registry of 
total hip replacements (THR) for Iceland for the years 1972 to 
1996, and a national Icelandic genealogy record. Familial cluster- 
ing of cases with THR for OA was identified by combining informa- 
tion from the two databases. The minimum number of founders 
(ancestors) required to account for all 2713 patients with THR for 
OA was estimated and compared with the corresponding average 
number of founders generated from an analysis of 500 similar 
sized matched control groups from the Icelandic population. The 
kinship coefficient analyzed the probability of identity by descent of 
two randomly chosen chromosomal oci in any two related individ- 
uals, out of which at least one had a THR. The relative risk of being 
operated on with THR for OA was calculated for siblings, first 
cousins and spouses of individuals with THR, and again compared 
with control groups from the population. 
Results: A large number of familial clusters of patients with THR 
for OA was identified; at a meiotic distance of 5 about 3 out of 4 
patients with THR for OA in the Icelandic population belonged to a 
cluster. The number of founders that accounted for patients with 
THR for OA was significantly less (p<0.00001) than that for similar 
sized control groups in the average population. The degree of 
kinship among patients with THR for OA was greater than average 
in the population (p<0.00001). The relative risk of 2.6-fold 
increased for siblings of patients with THR for OA to have under- 
gone the same procedure, while the risk for their spouses was 1, 
compared with the general population. 
Conclusions: The statistical methods applied in this population- 
based study demonstrate that Icelandic THR OA patients are 
significantly more related to each other than controls from the 
general population. These findings extend previous studies that 
support a significant genetic contribution to common forms of OA. 
Our study further encourages the search for genes responsible for 
an increased susceptibility for OA in the Icelandic population. 
Clinical 003 
HIGH BMD INCREASES THE RISK OF NEW HIP OA IN 
ELDERLY WOMEN, BUT OSTEOPOROSIS IS NOT 
PROTECTIVE 
M. Nevitt, N. Lane, M. Hochberg, E. William, for the SOF Research 
Group 
Universities of California, San Francisco and Maryland, Baltimore, 
USA 
In cross-sectional studies women with radiographic hip OA 
(RHOA) have increased BMD at the hip and peripheral sites. We 
performed a prospective study of the relationship between base- 
line BMD, prevalent vertebral fractures (PVFX), and new RHOA 
among women age _>65 in the Study of Osteoporotic Fractures 
(SOF). AP pelvis x-rays were obtained 8.0 (SD 0.4) years apart in 
5,987 women, 73% of survivors. Paired x-rays were assessed 
blinded to order for individual radiographic features (IRFs) of hip 
OA and measurement of minimal joint space (MJS). Total hip BMD 
was assessed by DXA (Hologic QDR 1000) and radius BMD by 
SPA (Osteon Osteoanalyzer). PVFX were assessed by morphom- 
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etry from lateral spine x-rays. In women without RHOA at baseline, 
we calculated odds ratios (OR) for the association of age-adjusted 
quartiles of BMD and PVFX with new RHOA (>_2 new IRFs), new 
osteophytes and new MJS < 1.5 mm. Logistic regression was used 
to estimate ORs in a hip-based analysis, with GEE to account for 
within subject correlation, adjusted for age, estrogen use, weight, 
height, physical activity, and smoking. 
% new RHOA (OR) by Age-adj. BMD Ouatlile 
Q1 Q2 03 Q4 
RHOA 2.3% (1.0) 25% (1.2) 3.2°° (1.6) 4.7% (2.3)" 
Osleophytes 27% (1 0) 36% (14) 3.9% (15) ° 4.7% (1.9)'" 
MJS~I 5 mm 27% (10) 2.2% (08) 2.6% (10) 26% (1.0) 
°P <.05. "P  <.01 
Women with high hip BMD had a greater risk of new RHOA and 
osteophytes, but not loss of joint space, a marker for severe OA. 
Results were similar for radius BMD. In contrast, women with 2 or 
more (vs. none) PVFX had an increased risk of RHOA, osteo- 
phytes and loss of joint space. We conclude that high BMD is a risk 
factor for an osteotrophic variant of RHOA in elderly women. 
However, osteoporosis may increase the risk of developing severe 
hip OA with loss of joint space. 
C l in i ca l  004  
A LONGITUDINAL STUDY OF THE RELATIONSHIP OF 
FRACTURE AND INCIDENT KNEE OSTEOARTHRITIS: THE 
CHINGFORD STUDY 
D. J. Hart, M. Daniels, C. Cronin, T. Worthy, D. V. Doyle and 
T. D. Spector 
Twin Research & Genetic Epidemiology Unit, St Thomas' Hospital 
& Rheumatology, Whipps Cross Hospital, London 
Studies examining risk of fracture in prevalent osteoarthritis (OA) 
found no overall lower risk of fracture (#) compared to the general 
population despite higher bone mass. We examined the associ- 
ation of having a previous fracture and risk of developing new 
osteoarthritis in middle-aged women from the general population. 
830 women (45-64 years) on whom radiographic data were 
available for incident OA were questioned for data on fractures 
over a 9 year period. All fractures were validated with evidence of 
an x-ray report or letter in patient notes. Radiographs were read for 
incident knee osteophytes using a standard atlas. 
265 fractures, including incident vertebral fracture, were reported 
over 9 year period. Fracture clearly unrelated to bone density were 
excluded from analysis (n= 16) leaving 249 fractures of which 206 
were confirmed as validated fractures. 95 women were identified 
as having incident knee OA. Women with fractures had lower 
BMD, were older and had reported more falls. Having a definite 
fracture provides a 60% protective effect against subsequently 
developing incident OA with an odds ratio OR95%CI 0.38 (0.17- 
0.87) adjusting for age, height, weight, ERT, smoking, bone density 
and falls. Reduced rates of OA were also seen following previous 
colles # OR 0.40(0.11-1.49) and vertebral # OR 0.20 (0.27-1.61) 
although confidence intervals included unity. Confining the analy- 
sis to the 182 fractures occurring definitely before the incident 
radiological OA made no difference to the results OR 0.40(0.17- 
0.92). Despite small numbers, some evidence for high protection 
was also seen for past fracture in the 30 women whose knee OA 
had progressed radiographically over the subsequent 5 years OR 
0.67 (0.17-2.67). 
In summary women with a history of fracture appear to be 
protected against developing radiological OA regardless of age, 
ERT use and bone density status. The mechanism for this 
observation are unclear, but could provide helpful insights into the 
pathogenesis of osteoarthritis. 
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Clinical 005 
THE PRECISION AND REJECTION RATES FOR THE 
MEASUREMENT OF JOINT SPACE WIDTH IN A LARGE 
MULTICENTER STUDY 
M. Kothari, M Sieffert, G. von Ingersleben, H. Kramer, D. Lissin, 
J. Li, Y. Miaux, R, M. Stevens*, C. Peterfy 
Synarc, Inc., San Francisco, USA 
*Hoffman La Roche, Inc., Nutley, New Jersey, USA 
Joint space narrowing (JSN) is currently the primary quantitative 
structural endpoint for assessing disease progression in osteo- 
arthritis. JSN is determined by longitudinal measurement of 
minimum joint space width (min-JSW). Recently, computer- 
assisted measurements of min-JSW using digitized radiographs 
have been developed. Single-center studies have shown that 
these measurements show greater precision and lower inter- 
reader variability than manual measurements and hence are better 
suited for the longitudinal evaluation of JSN 1'2. Multicenter imaging 
introduces additional vari.ability. Small multicenter studies using the 
fluoroscopic semi-flexed AP view have reported precision errors 
(std. errors of repeat measures) to be 0.45 mm and 0.42 mm for all 
paired radiographs and high-quality radiographs respectively 3. In 
order to limit the study to high quality radiographs, the rejection 
rate was very high - 55.7% if both intermediate and low quality 
radiographs were rejected, and 29% if only low quality radiographs 
were rejected 3. The aim of this study was to examine precision of 
min-JSW measures and rejection rates in a multicenter study using 
a non-fluoroscopic x-ray technique. 
Methods: Knee images of 457 osteoarthritic patients (326 
women: 61 yr.±8 yr.; 131 men: 62 yr.±8 yr.) were acquired at 58 
different centers in the US. At each center, both knees were 
imaged on separate films using posteroanterior, weight bearing, 
fixed-flexion non-fluoroscopic radiography with 10 ° beam angula- 
tion ~. Positioning was aided by a specially designed frame. Repeat 
films were obtained in a subset of 30 knees from 14 centers. 
Manual min-JSW measures were made by an experienced 
radiologist (Gvl). Computer-assisted measurements were also 
made with a validated edge detection technique 4 and were verified 
by an experienced radiologist (YM). Min-JSW was measured two 
times using both the manual and computer-assisted technique in 
order to obtain precision measures. Quality assurance criteria for 
film acceptance/rejection were defined prior to study initiation, and 
maintained throughout he study. Quality assurance was done by 
trained readers (Gvl, DL, JL). Criteria included delineation of the 
articular cortex of the tibia appropriate anatomical projection of the 
tibial spines within the femoral notch, image exposure and stability 
of projectional relationships among anatomical landmarks on 
serially acquired images. 
Results: As indicated by previous single-center studies, the 
computer-assisted technique offered improved precision over the 
manual measures. For medial min-JSW, the standard deviation of 
the min-JSW measurements was 0.25 mm using the computer- 
assisted measures and 0.42 mm using the manual technique. The 
corresponding coefficients of variation were 4.1% and 6.2% 
respectively. The overall rejection rate was 9.86%. 
Conclusions: These results show that posteroanterior, weight 
bearing, fixed-flexion on-fluoroscopic radiography with 10 ° beam 
angulation and positioning frame provides precise min-JSW 
measurements in a multicenter setting, with a concomitant 
rejection rate of 9.9%. A smaller, three-center study using the 
fluoroscopic technique showed somewhat worse precision, but a 
higher rejection rate of 29%. It should be recognized that these two 
parameters, namely improving precision and lowering rejection 
rates, are competing objectives in clinical trials. 
References 
1. Peterfy CG et al. Arthritis Rheum 1998; 41 (9): $361 
2. Buckland-Wright C et al. J Rheumatol 26(12): 2664-74 
3. Mazzuca SA et al. J Rheumatol 26(6): 1359-65 
4. Duryea Je t  al. Arthritis Rheum 1999; 42(9): $143 
Clinical 006 
VARIABLES RELATED TO CONCOMITANT USE OF 
GASTROPROTECTIVE AGENTS AMONG CHRONIC NSAID 
USERS 
T. J. Schnitzer*, S. X. Kongt, K. H. Kahlert, D. J. Watson:l:, 
W. L. Strausl 
*Office of Clinical Research and Training, Northwestern University, 
Chicago, IL, USA. tOutcomes Research, Merck & Co., Inc., 
Whitehouse Station, NJ, USA; ~.Epidemiology, Merck Research 
Laboratories, Blue Bell, PA, USA 
Objective: Age is a well described risk factor for developing GI 
adverse events and various guidelines have advocated use of 
gastroprotective agents (GPAs) in older individuals initiating 
chronic NSAID therapy. In this study, the relationship between age, 
sex, choice of NSAID, and GPA use was investigated in chronic 
NSAID users. 
Methods: A US prescription database for 1998 was employed to 
identify individuals who were new NSAID users and evaluate their 
subsequent use of NSAIDs and concomitant GPAs. All individuals 
with at least one prescription (Rx) for any NSAID between May 1 
and August 31, 1998, were identified; those having an NSAID Rx 
during the preceding 4 months were exluded. Of the remaining 
group, those having at least 30-day supply of NSAID during the 
120 days subsequent to their first NSAID Rx were considered 
chronic NSAID users. Those subjects with GPA Rx anytime 
between the NSAID Rx and 125% days' supply were considered to 
have concomitant GPA. Specific NSAIDs identified included 
Arthrotec, diclofenac, ibuprofen, nabumetone, naproxen and 
'other'; GPAs included proton pump inhibitors, H2-antagonists and 
misoprostol. Subjects were assigned to a particular NSAID based 
on the first NSAID Rx received. 
Results: 48% (1,449,208) of all new NSAID users were classi- 
fied as chronic. Chronic NSAID use was markedly higher in women 
than men (1.7x) and appeared independent of NSAID type. Age 
distribution among different NSAIDs was similar except for a higher 
number of older (> 65 yrs) people utilizing Arthrotec and nabume- 
tone. Over a period of three months, the concomitant use of GPAs 
among chronic NSAID users was 14%; by NSAID, rates were: 22% 
Arthrotec, 16% diclofenac, 11% ibuprofen, 17% nabumetone, 11% 
naproxen, and 14% other NSAID users. The best predictor of 
concomitant GPA use was prior GPA use, with 70% of those 
previously on GPAs receiving continued therapy. In chronic NSAID 
users, GPA use was strongly associated with age overall (> 2 fold 
increase in those > 75 yrs vs < 55 yrs); when examined for 
individual NSAIDs, this was true for all NSAIDs except Arthrotec. 
Discussion: Prior GPA use was the strongest predictor of GPA 
use with NSAIDs. Substantial differences in GPA use among 
patients on different NSAIDs were observed and these may reflect 
perceived underlying patients' GI risk and perceived variation in GI 
safety profiles of different NSAIDs. 
Clinical 007 
A LONG-TERM, RANDOMISED, PLACEBO-CONTROLLED, 
CONFIRMATORY TRIAL ON THE EFFECTS OF 
GLUCOSAMINE SULFATE ON KNEE OSTEOARTHRITIS 
PROGRESSION 
K: Vavelka*, J. Gatterova*, M. Olejarova °, S. Machacek*, 
G. Giacovellit, L. C. Rovatit 
*/nstitute of Rheurnato/ogy, Prague, Czech Republic, t Rotta 
Research Lab., Monza, /ta/y 
Aim of the study: Glucosamine sulfate has been recently shown 
to be able to improve knee OA symptoms and to prevent radio- 
logical mean joint space narrowing (JSN) over a 3-year treatment 
course, as assessed by digital image analysis [Arthritis Rheum 
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1999;42 (suppl):1975]. This separate study was conducted to 
confirm and extend those results by slightly different echniques. 
Methods: The trial was conducted according to a prospective, 
randomised, placebo-controlled, ouble-blind esign. Out-patients 
with knee OA were selected according to the ACR criteria: 202 
patients were randomised to the oral treatment with glucosamine 
sulfate 1500 mg once-a-day, or matching placebo for 3 years. The 
minimum joint space width (JSW) of the narrowest medial com- 
partment of the tibio-femoral joint was measured visually by a 
0.1 mm graduated magnifying glass, on standardised weight- 
bearing antero-posterior radiographs of each knee. Symptoms 
were assessed by both the WOMAC LK 3.0 version and the 
Lequesne indices. 
Results: The overall patient population had a mean age of 62 
years (rage 44-76), body mass index of 26 (18-33) and consisted 
of 78% women: the two treatment groups of 101 patients each had 
similar demographic and disease characteristics, with symptoms of 
mild to moderate severity. Slightly more patients left the study in 
the placebo group (total 46%; 10% for adverse events) than in the 
glucosamine sulfate group (total 35%; 8% for adverse events). 
Final changes from enrolment (L~) were analysed by both a 
per-protocol (PP) approach on study completers and a worst case 
scenario intention-to-treat (ITT), assigning to missing values the 
final average change observed with placebo (table). The 3-year 
JSN observed with placebo was approximately 0.2 mm and was 
significantly higher than with glucosamine sulfate, for which no 
JSN occurred in average. Symptoms improved in both groups, but 
significantly more with glucosamine sulfate than with placebo. The 
improvement tended to be proportionally higher on the Lequesne 
index (20-25% with glucosamine sulfate vs. <10% with placebo) 
than on the WOMAC (15-20% vs. <2%). 
Per-prolocol (PP) 
Placebo 
N=54 N=62 
JSW enrolment (mm) 3.72 (0.21) 
JSN 3 years (mm) -0.19 (0.10) 
N=54 N=66 
_equesne enrolmenl (points) 8.5 (0.3) 
~, 3 years (points) -08  (0.3) 
~VOMAC enrolmenl (points) 28.6 (1.9) 29.1 (1.7) 
.'~ 3 years (points) -4.g (1.5) -97  (1.3)" 
Data are means (SE). 'p<O.05 and "'p<0.005 vs. placebo. 
Glucosamlne 
sulfate 
4.07 (0,19) 
+0.16 (0.08)" 
8.8 (0.3) 
-22  (0.4) '° 
Inlentton-to-treal (ITT) 
Glucosamine 
Placebo sulfale 
N=101 N=101 
3.59 (016) 397 (0.14) 
-0,19 (0,05) +0.02 (0.05} °' 
N=101 N=101 
8.9 (0.2) 90 (0.2) 
-0.8(0.2) - 1.7 (0.2)" 
30,5 ( 1.4) 30.7 (1.4) 
-4.9 (0,8) -8.0 (0.9)' 
Conclusions: This study confirmed that the natural JSN in knee 
OA is slow (< 0.1 mm/year on average), but can be prevented by 
glucosamine sulfate that also induces a significant symptom 
improvement. 
Cl inical 008 
DYNAMIC LOAD AT BASELINE CAN PREDICT 
RADIOGRAPHIC DISEASE PROGRESSION OF 
TIBIOFEMORAL OSTEOARTHRITIS 
M. Wada, H. Tatsuo, M. Sato, H. Kawahara, S. Shimada, 
S. Sasaki, Y. Nose, H. Baba 
Division of Rehabilitation Medicine and Department of Orthopaedic 
Surgery, Fukui Medical University, Fukui, Japan 
Objectives: In longitudinal studies, several factors have been 
proposed to influence the progression of osteoarthritis (OA) of the 
knee. However, only a few biomechanical factors have been 
evaluated with respect to their effect on prognosis. Dynamic load 
may significantly influence prognosis, but its long-term effect has 
not yet been established. Here we tested the hypothesis that 
dynamic load at baseline can predict radiographic disease 
progression of tibiofemoral OA at more than five-year follow-up. 
Methods: During 1990-1994, baseline data were collected by 
radiography, gait analysis and muscle strength around the knee in 
52 hospital-referred patients with medial compartment knee OA. 
They included 12 men and 40 women with a mean age of 68 years. 
After a mean follow-up period of 6.5 years (range, 5-9 years), 
repeat radiographs were obtained and compared with the baseline 
for joint space width. 
Results: Radiographic progression (joint space in the medial 
compartment decreased by >2 mm) was seen in 50 out of 60 
knees (83%) in the high adduction moment group (peak adduction 
moment >5%) compared to 5 out of 44 knees (11%) in the low 
adduction moment group. In addition, 10 out of 60 knees (17%) in 
the high adduction moment group did not show radiographic 
progression compared to 39 out of 44 knees (89%) in the low 
adduction moment group. However, no significant differences were 
noted when the above parameter was divided by baseline body 
weight, muscle strength or varus alignment. Using a multivariate 
Cox proportional hazard model, only adduction moment correlated 
significantly with radiographic disease progression at > 5-year 
follow-up, with a hazard ratio of 9.42 (95% confidence interval, 
range, 2.4 to 37.2) between highest and lowest groups, after 
adjusting for gender, baseline age, body weight, extension or 
flexion muscle strength, joint space width and varus alignment of 
the knee. 
Conclusions: Baseline adduction moment of the knee, which 
reflects dynamic load on the medial compartment, can predict 
radiographic OA progression at more than 5-year follow-up in 
hospital referred patients wth medial compartment knee OA. 
